Vascular hemichorea/hemiballism and topiramate
- 4 March 2004
- journal article
- case report
- Published by Wiley in Movement Disorders
- Vol. 19 (7) , 836-838
Abstract
Although vascular hemichorea/hemiballism (HC/HB) has been reported to be self‐limited, in some cases, it can be irreversible and severely disabling. The standard treatment includes typical and atypical neuroleptics and GABA‐mimetic drugs. Topiramate is a new antiepileptic drug possessing a complex mechanism of action, including the enhancement of GABA‐mediated inhibition. We describe a 71‐year‐old patient with HC/HB who markedly improved after topiramate treatment. © 2004 Movement Disorder SocietyKeywords
This publication has 15 references indexed in Scilit:
- Cause and course in a series of patients with sporadic choreaJournal of Neurology, 2003
- A double-blind placebo-controlled trial of topiramate treatment for essential tremorNeurology, 2002
- TopiramateEpilepsia, 1999
- Hyperkinetic movement disorders during and after acute stroke: The Lausanne Stroke RegistryJournal of the Neurological Sciences, 1997
- Hemichorea after a striatal ischemic lesion: Evidence of thalamic disinhibition using single‐photon emission computed tomography: A case reportMovement Disorders, 1996
- Inconsistent response to divalproex sodium in hemichorea/hemiballismNeurology, 1990
- Primate models of movement disorders of basal ganglia originTrends in Neurosciences, 1990
- Hemiballism-HemichoreaArchives of Neurology, 1989
- Hemichorea‐hemiballism and lacunar infarction in the basal gangliaNeurology, 1981
- Treatment of vascular hemiballism and hemichoreaNeurology, 1977